Conference programme
ESCAIDE 2019
Take a look back at 2019 programme and stay tuned for ESCAIDE 2020 programming announcements.
|
Time |
Day 1, Wednesday 27 November 2019 |
Day 2, Thursday 28 November 2019 |
Day 3, Friday 29 November 2019 |
|---|---|---|---|
|
8:15 - |
Registration & coffee |
Registration |
Registration |
|
9:00-10:30 |
Welcome (09:00- 09:15)
Plenary session A: “Health security and preparedness: lessons from Ebola"
Dr. Mike Ryan, World Health Organization, Switzerland
Chair: Prof. Mike Catchpole (ECDC) |
Plenary session C: “The microbiome: what you need to know”
Dr. Sean Gibbons, Institute for Systems Biology, United States of America Prof. Debby Bogaert, The University of Edinburgh, United Kingdom
Chairs: Dr. João André Carriço (Medical University of Lisbon, Portugal); Dr. Christopher Barbara (Mater Dei Hospital, Malta) |
Plenary session D: “How should public health research priorities be defined, and what should they be?” Dr. Ed Whiting, Wellcome Trust, United Kingdom Dr. Lina Moses, School of Public Health & Tropical Medicine/ Tulane University, United States of America Dr. Jean- Claude Desenclos, IANPHI, Public Health France
Chairs: Dr. Maria Van Kerkhove (WHO HQ); Dr. Frode Forland (Norwegian Institute of Public Health); Amrish Baidjoe (WHO-South-East Asia Regional Office) |
|
10:30-11:00 |
Refreshments |
Refreshments |
Refreshments |
|
11:00-12:40 |
Parallel sessions 1. Emerging and vector-borne diseases: surveillance approaches 2. Vaccine-preventable diseases: vaccine coverage, safety and uptake 3. Healthcare-associated infections: burden and prevention |
Parallel sessions 7. Food- and waterborne diseases and zoonoses: public health microbiology and surveillance methods 8. Vaccine-preventable diseases: surveillance (1) 9. Influenza: vaccination and intervention (1) |
Parallel sessions 16. Vaccine-preventable diseases: epidemiology 17. Hepatitis B and C: surveillance and disease burden 18. Food- and waterborne diseases and zoonoses outbreaks (2) |
|
12:40 -14:30 |
Lunch / Eurosurveillance seminar |
Lunch/ EAN General Assembly meeting |
Lunch/ Career compass |
|
14:30-15:30 |
Parallel sessions 4. Antimicrobial resistance and healthcare-associated infections: epidemiology 5. Emerging and vector-borne diseases: epidemiology 6. Food- and waterborne diseases and zoonoses outbreaks (1) |
Parallel sessions 10. Antimicrobial resistance and healthcare-associated infections: surveillance 11. Late breakers 12. Influenza: vaccination and intervention (2) |
Parallel sessions 19. Vaccine-preventable diseases surveillance (3) 20. Food- and waterborne diseases and zoonoses surveillance 21. Late breakers |
|
15:40-16:40 |
Moderated poster session 1. Antimicrobial resistance 2. Emerging and vector-borne diseases, and international health (1) 3. Food- and waterborne diseases and zoonoses (1): outbreaks (I) 4. Food- and waterborne diseases and zoonoses (2): surveillance 5. Influenza and other respiratory viruses (1) 6. HIV, sexually transmitted infections and viral hepatitis (1): surveillance and burden of disease 7. Vaccine-preventable diseases (1): measles 8. Vaccine-preventable diseases (2): surveillance |
Moderated poster session 9. Healthcare-associated infections 10. Emerging and vector-borne diseases, and International health (2): vector-borne diseases 11. Food- and waterborne diseases (3): epidemiology and burden of disease 12. Food- and waterborne diseases and zoonoses (4): public health microbiology 13. HIV, sexually transmitted infections and viral hepatitis (2): intervention 14. Tuberculosis and other respiratory diseases (excluding viruses) (1): surveillance and modelling 15. Influenza and other respiratory viruses (2): vaccination and interventions 16. Vaccine-preventable diseases (2) |
Moderated poster session 17. Food- and waterborne diseases and zoonoses (5): outbreaks (II) 18. Tuberculosis and other respiratory diseases (excluding viruses) (2): epidemiology 19. Emerging and vector-borne diseases and International health (3): surveillance approaches 20. HIV, sexually transmitted infections and viral hepatitis (III): surveillance & epidemiology 21. Influenza and other respiratory viruses (3): Human Respiratory Syncytial virus 22. Influenza and other respiratory viruses (4) 23. Vaccine-preventable diseases (4): vaccine coverage, uptake and response 24. Late breakers
|
|
16:40-17:00 |
Refreshments |
Refreshments |
Refreshments |
|
17:00-18:30 |
Plenary session B: “Vaccine confidence in a post-factual world”
Prof. Dr. Wolfgang Gaissmaier, Social Psychology and Decision Sciences, University of Konstanz Dr. Robb Butler, WHO Regional Office for Europe
Chairs: Prof. Dr. Bojana Beović (University of Ljubljana Slovenia); Dr. Frantiska Hruba (ECDC).
|
Parallel sessions 13. HIV and STI: prevalence and prevention 14. Respiratory disease: surveillance and modelling 15. Vaccine-preventable diseases surveillance (2) |
Plenary session E: “Climate change: Addressing the public health challenge in Europe”
Dr. Henriette De Valk, Public Health France Prof. Dr. Ana Maria de Roda Husman, National Institute for Public Health and the Environment, The Netherlands
Chairs: Dr Susan Hahné (National Institute for Public Health and the Environment) and Prof. Dr. Aura Timen (National Institute for Public Health and the Environment and Free University of Amsterdam) |
|
|
Reception (18:45- 21:00) |
BarCamp (18:45- 20:00) |
Closing Ceremony and EAN prizes award (18:30- 18:40) |